enGene Reports Second Quarter 2025 Financial Results and Provides Business Update

enGene Holdings Inc. (Nasdaq: ENGN, or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced its financial resul…Read More